the aid library

LIST OPTIONS

Filter

2562

Sort by:

Direction:

Download (152)

View PDF (480)

Le Changement de paradigme - Le Plan Mondial pour Éliminer la Tuberculose (TB) 2016-2020

Stop TB Partnership; UNOPS; END TB (2015) C1

Download (68)

View PDF (106)

Thematic segment: Mental Health and HIV/AIDS – Promoting human rights, an integrated and person-centered approach to improving art adherence, well-being and quality of life

UNAIDS; STRIVE (2018) C2

1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018 UNAIDS/PCB (43)/18.32

Download (48)

View PDF (119)

Disponibilite et capacite operationnelle des services de sante, Enquête SARA, 2015

Le Ministre de la Santé, République du Bénin (2015) C2

L’enquête SARA a pour objectif d’évaluer la disponibilité, la capacité opérationnelle des services de santé au Bénin et la qualité des données du Système National d’Informations et de Gestion Sanitaires (SNIGS). Elle a été menée dans 788 formations sanitaires réparties sur toutes... more

Download (838)

View PDF (2011)

Essentials For Emergencies

World Health Organization (2004) C_WHO

The purpose of this booklet is to assist WHO and other Public Health workers in the field when an emergency occurs. The booklet provides technical hints on how to carry out a rapid health assessment, how to facilitate coordination, how departments in WHO can assist, etc. Standard formats for re... more

Download (106)

View PDF (130)

Amélioration des estimations ONUSIDA relatives au VIH chez les enfants et les adolescents

ONUSIDA (2019) C2

Accessed: 02.11.2019

Download (106)

View PDF (102)

Directives Nationales de Santé des nouveau-nes au Bénin

République du Bénin Ministère de la Santé Direction de la Santé de la Mère et de l’Enfan (2015) C2

Les périodes périnatale et néonatale constituent des moments critiques dans la vie des mères et des nouveau-nés. En effet, pendant ces périodes, des complications obstétricales, foetales et néonatales surviennent entrainant des mort-nés, des décès néonatals et des possibilités d’incap... more

Download (125)

View PDF (900)

Interferon-γ-Tests in der Tuberkulose-Diagnostik - Aktueller Stand

B. Hauer, R. Loddenkemper, A. Detjen, et al. (2006) C2

Interferon-γ Assays - Description and Assessment of a New Tool in the Diagnosis of Tuberculosis. Haür B et al. Interferon-γ-Tests in der ...Pneumologie 2006; 60: 29-44

Download (1021)

View PDF (1458)

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

John R. Perfect, William E. Dismukes, Francoise Dromer, et al. Infectious Diseases Society of America (2010)

Clinical Infectious Diseases 2010; 50:291–322

Download (1201)

View PDF (1723)

Utilisation de sang total ou de plasma de convalescent recueilli chez des patients rétablis après une maladie à virus Ebola pour la transfusion, comme traitement empirique pendant les épidémies

Organisation Mondiale de la Santé OMS (2014)

Download (487)

View PDF (838)

Warehouse information system assessment

MSH Management Sciences for Health (MSH) (1996) C1

PURPOSE: To assess the appropriateness of computerizing a health facility warehouse. If users are interested in receiving technical assistance to improve and/or computerize the logistics information system, Management Sciences for Health (MSH) will analyze the responses to determine the initial step... more

Download (111)

View PDF (1042)

Finding the Missing Tuberculosis Patients

D. P. Chin, C. L. Hanson The Journal of Infectious Disease; IDSA; Oxford, et al. (2017) C2

Supplement article The Journal of Infectious Diseases® 2017;216(S7):S675–8 DOI: 10.1093/infdis/jix368 Finding the Missing Tuberculosis Patients • JID 2017:216 (Suppl 7) • S675 Downloaded from https://academic.oup.com/jid/article-abstract/216/suppl_7/S675/4595547 by guest on 13 Nove... more

Download (984)

View PDF (1443)

Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-limited Settings

World Health Organization WHO (1999) C_WHO

These guidelines are designed for settings with limited resources to provide inexpensive and effective control strategies for prevention of TB transmission in health care workers (HCW).

Download (292)

View PDF (198)

National Essential Diagnostic List
recommended

Indian Council of Medical Research India (2019) CC

Download (71)

View PDF (101)

Guidance on administration of COVID-19 vaccine boosters in Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so... more

Download (53)

View PDF (82)

Aligning health and decentralization reform in Ukraine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Ukrainian decentralization reform has increased and democratized local government responsibility for health care at the level of local government closest to communities and has increased regional and local government responsibility for public health. Decentralization affects health system reform in ... more

Download (97)

View PDF (131)

Training on GLASS methodology for national surveillance of antimicrobial consumption

World Health Organization WHO (2022) C_WHO

Download (98)

View PDF (128)

Mettre fin au Choléra -feuille de route mondiale pour 2030
recommended

Global Task Force on Cholera Control (GTFCC) (2017) C_WHO

Mettre fin au choléra- Feuille de route mondiale pour 2030 rend opérationnelle la nouvelle stratégie mondiale de lutte contre le choléra au niveau des pays et fournit une voie concrète vers un monde où le choléra ne représente plus une menace pour la santé publique. En mettant en œuvre la ... more

Download (71)

View PDF (72)

Cholera in the WHO African Region: Weekly Regional Cholera Bulletin: 17 July 2023

World Health Organisation (WHO) (2023) C_WHO

The cholera outbreak has affected 14 countries in the WHO African Region. The climate-induced natural disasters such as cyclone and flooding in the southern African region and drought in the Horn of Africa led to increase in cases of cholera in many of the affected countries. With the rainy season c... more

Download (96)

View PDF (111)

Considerations for developing a national genomic surveillance strategy or action plan for pathogens with pandemic and epidemic potential

World Health Organization WHO (2023) C_WHO

Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

National Essential Diagnostic List recommended

Guidance on administration of COVID-19 vaccine boosters in Africa recommended

Mettre fin au Choléra -feuille de route mondiale pour 2030 recommended

National Essential Diagnostic List
recommended

Guidance on administration of COVID-19 vaccine boosters in Africa
recommended

Mettre fin au Choléra -feuille de route mondiale pour 2030
recommended